Prosecution Insights
Last updated: April 19, 2026

Fujifilm Toyama Chemical Co. Ltd.

3 pending office actions

Portfolio Summary

3
Total Pending OAs
2
Final Rejections
1
Non-Final OAs

Pending Office Actions

App #TitleExaminerArt UnitStatusFiled
18554291 THERAPEUTIC AGENT FOR CORONAVIRUS INFECTION AULAKH, CHARANJIT 1621 Non-Final OA Oct 06, 2023
18256153 PHARMACEUTICAL COMPOSITION NESTOR, DONNA MICHELLE 1627 Final Rejection Jun 06, 2023
17997422 CORONAVIRUS INFECTION THERAPEUTIC AGENT FORMED THROUGH COMBINATION OF PYRAZINE DERIVATIVE AND ANOTHER CORONAVIRUS INFECTION THERAPEUTIC DRUG NOLAN, JASON MICHAEL 1623 Final Rejection Oct 28, 2022

Managing Fujifilm Toyama Chemical Co. Ltd.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month